Medical Management of Swallowing Disorders


Dysphagia or difficulty in swallowing is a problem in all age groups but more so in the elderly. It can be either primarily oropharyngeal or esophageal in origin. Patients with oropharyngeal dysphagia can present with symptoms of coughing or choking with swallowing, food sticking in throat, drooling, nasal regurgitation, weight loss, and episodes of recurrent pneumonia. Esophageal dysphagia can lead to sensation of food sticking in chest, oral or pharyngeal regurgitation, food sticking in throat, drooling, and weight loss [1]. Elderly population with dysphagia has a higher risk of malnutrition, nonhealing wounds, bed sores, and aspiration pneumonia. This is especially common in patients with dysphagia due to neurological diseases, neurodegenerative diseases, or brain injury. A study using Subjective Global Assessment to assess nutritional status found that 16 % of patients with dysphagia related to brain disorders had concomitant malnutrition whereas 22 % of patients with neurodegenerative diseases had associated malnutrition [2].


Lower Esophageal Sphincter Acid Reflux Eosinophilic Esophagitis Pneumatic Dilatation Oropharyngeal Dysphagia 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. 1.
    Castell DO, Donner MW. Evaluation of dysphagia: a careful history is crucial. Dysphagia. 1987;2:65–71.CrossRefPubMedGoogle Scholar
  2. 2.
    Palmer JB, et al. Evaluation and treatment of swallowing impairments. Am Fam Physician. 2000;61(8):2453–62.PubMedGoogle Scholar
  3. 3.
    Crary MA, Groher ME. Introduction to adult swallowing disorders. Philadelphia: Butterworth Heinemann; 2003.Google Scholar
  4. 4.
    DeVries DR, et al. Gastroesophageal reflux disease, relation with hiatal hernia, body mass index, esophageal acid exposure. Am J Gastroenterol. 2008;103:1349–54.CrossRefGoogle Scholar
  5. 5.
    Corley DA, Kubo A, Levin TR, et al. Abdominal obesity and body mass index at risk patients for Barett’s esophagus. Gastroenterology. 2007;133:34–41.CrossRefPubMedGoogle Scholar
  6. 6.
    Hirshowitz BI, Simmons J, et al. Risk factors for esophagitis in extreme acid hyper secretion with or without Zollinger-Ellison syndrome. Clin Gastroenterol Hepatol. 2004;2:220–9.CrossRefGoogle Scholar
  7. 7.
    Dellon ES, Shaeen NJ. Does screening for Barrett’s esophagus and adenocarcinoma prolong survival? J Clin Oncol. 2005;23:4478–82.CrossRefPubMedGoogle Scholar
  8. 8.
    Vakil N, Van Zarter SV, Kahriks P, et al. The Montreal Definition and classification of GERD: a global evidence based consensus. Am J Gastroenterol. 2006;101:1900–2000.CrossRefPubMedGoogle Scholar
  9. 9.
    Armstrong D, Marshall JK, Chiba N, et al. Canadian Consensus Conference on the management of gastroesophageal reflux disease in adults. Update 2004. Can J Gastroenterol. 2004;19:15–35.Google Scholar
  10. 10.
    Kahrilas PJ, Shaeen NJ, Vaezi M. Management of gastroesophageal reflux disease. Gastroenterology. 2008;135:1392–413.CrossRefPubMedGoogle Scholar
  11. 11.
    Khan M, Santana J, Donellan C, Preston C, Moayyedi P. Medical treatments in the short term management of reflux esophagitis. Cochrane Database Syst Rev. 2007;2:CD003244.PubMedGoogle Scholar
  12. 12.
    Shaeen N, Ransohoff DF. Gastroesophageal reflux, Barrett’s esophagus and esophageal cancer: scientific review. JAMA. 2002;287:1972–81.CrossRefGoogle Scholar
  13. 13.
    Sethumadavan S, Ramanathan J, Rammouni R, et al. An overview. Am J Gastroenterol. 2001;96:226.Google Scholar
  14. 14.
    Baehr PH, McDonald GB. Esophageal infections: risk factors, presentations, diagnosis and treatment. Gastroenterology. 1994;106:509.PubMedGoogle Scholar
  15. 15.
    Mc Cord GS, Clouse RE. Pill-induced esophageal structures. Clinical features and risk factors for development. Am J Med. 1990;88:512.CrossRefGoogle Scholar
  16. 16.
    Bova JG, Dutton NE, Godstein HM, et al. Medication -induced esophagitis: diagnosis by double-contrast esophagography. Am J Roentgenol. 1987;148:731.CrossRefGoogle Scholar
  17. 17.
    Edwards P, Turner J, Gold J, et al. Esophageal ulceration induced by zidovudine. Ann Intern Med. 1990;91:27.Google Scholar
  18. 18.
    Indorff A, Pergram PS. Esophageal ulceration related to zalcitabine. Ann Intern Med. 1992;117:133.CrossRefGoogle Scholar
  19. 19.
    De Groen PC, Lubbe CF, Hirsch LJ, et al. Esophagitis associated with the use of alendronate. N Engl J Med. 1996;335:1016.CrossRefPubMedGoogle Scholar
  20. 20.
    Macebo G, Azevedo F, Riberio T. Ulcerative esophagitis caused by etidronate. Gastrointest Endosc. 2001;53:250.CrossRefGoogle Scholar
  21. 21.
    Licking EG, Argueta R, Whitaker MD, et al. Pamidronate: an unrecognised problem in gastrointestinal tolerability. Osteoporos Int. 1994;4:320.CrossRefGoogle Scholar
  22. 22.
    Kikendall JW. Pill- induced esophageal injury. In: Castell DO, Richter JE, editors. The esophagus. 4th ed. Philadelphia: Lippincott Williams & Wilkins; 2004. p. 572.Google Scholar
  23. 23.
    Schubert MM, Peterson DE, Lloid ME. Oral complications in hematopoietic cell transplantation. 2nd ed. Cambridge: Blakwell Science; 1999. p. 751.Google Scholar
  24. 24.
    Hey H, Jorgensen F, Sirensen K, et al. Esophageal transit of six commonly used tablets & capsules. BMJ. 1982;285:1717.CrossRefPubMedCentralPubMedGoogle Scholar
  25. 25.
    Pandolfino JE, Kwiatek MA, Nealis T, et al. Achalasia: a new clinically relevant classification by high resolution Manometry. Gastroenterology. 2008;135:1526–33.CrossRefPubMedCentralPubMedGoogle Scholar
  26. 26.
    Csendes A, Smok G, Braghetto I, et al. Gastroesophageal sphincter pressure and histologic changes in distal esophagus in patients with achalasia. Dig Dis Sci. 1985;30:941–5.CrossRefPubMedGoogle Scholar
  27. 27.
    Boeckxstaens GE. Achalasia: virus- induced euthanasia of neurons. Am J Gastroenterol. 2008;103:1610–2.CrossRefPubMedGoogle Scholar
  28. 28.
    Facco M, Brun P, Baesso I, et al. T Cells in my enteric plexus of achalasia patients show a skewed TCR repertoire and react to HSV-1 antigens. Am J Gastroenterol. 2008;103:1598–609.CrossRefPubMedGoogle Scholar
  29. 29.
    Clark SB, Rice TW, Tubbs RR, et al. The nature of myenteric infiltrate in achalasia. An immunohistochemical analysis. Am J Surg Pathol. 2000;24:1153–8.CrossRefPubMedGoogle Scholar
  30. 30.
    Qualman SJ, Haupt HM, Yang P, Hamilton SR. Esophageal Lewy bodies associated with ganglion cell loss in achalasia. Gastroenterology. 1986;90:924–9.Google Scholar
  31. 31.
    Vantrappen G, Hellemans J. Treatment of achalasia and related motor disorders. Gastroenterology. 1980;79:144–54.PubMedGoogle Scholar
  32. 32.
    Drewes AM, Gregersen H. Multimodal pain stimulation of gastrointestinal tract. World J Gastroenterol. 2006;12:2477–86.PubMedCentralPubMedGoogle Scholar
  33. 33.
    Richter JE. Surgery or pneumatic dilatation for achalasia. A head to head comparison. Gastroenterology. 1989;97:1340–1.PubMedGoogle Scholar
  34. 34.
    Bortoletti M, Labo G. Clinical and manometric effects of patients in with esophageal achalasia. Gastroenterology. 1981;80:39–44.Google Scholar
  35. 35.
    Gelfond M, Rozen P, Gilat T. Isosorbide dinitrate and nifedipine treatment of achalasia. A clinical and manometric and radionuclide evaluation. Gastroenterology. 1982;83:963–9.PubMedGoogle Scholar
  36. 36.
    Traube M, Hongo M, Magyar L, McCallum RW. Effects of nifedipine in achalasia and in patients with high amplitude peristaltic esophageal contractions. JAMA. 1984;252:1733–6.CrossRefPubMedGoogle Scholar
  37. 37.
    Bortolotti M, Mari C, Lopilato C, et al. Effects of sildenafil on esophageal motility of patients with idiopathic achalasia. Gastroenterology. 2000;118:253–7.CrossRefPubMedGoogle Scholar
  38. 38.
    Pasricha PJ, Ravich WJ, Hendrix TR, et al. Intrasphincteric botulinum toxin for the treatment of achalasia. N Engl J Med. 1995;332:774–8.CrossRefPubMedGoogle Scholar
  39. 39.
    Rothenberg ME. Eosinophilic gastrointestinal disorders. J Allergy Clin Immunol. 2004;113:11–28.CrossRefPubMedGoogle Scholar
  40. 40.
    Lucendo AJ, Arias Á, González-Cervera J et al: Empiric 6-food elimination diet induced and maintained prolonged remission in patients with adult eosinophilic esophagitis: a prospective study on the food cause of the disease. J Allergy Clin Immunol. 2013;131(3):797–804. doi: 10.1016/j.jaci.2012.12.664. Epub 2013 Jan 31.
  41. 41.
    Ngo P, Furuta G, Antonioli D, Fox V. Eosinophils in the esophagus- peptic or allergic eosinophilic esophagitis? Case series of three patients with esophageal eosinophilia. Am J Gastroenterol. 2006;101:1666–70.CrossRefPubMedGoogle Scholar
  42. 42.
    Spechler SJ, Genta RM, Souza RF. Thoughts on complex relationship between GERD and eosinophilic esophagitis. Am J Gastroenterol. 2007;102:1301–6.CrossRefPubMedGoogle Scholar
  43. 43.
    Furuta GT, Liacouras CA, Collin MH, et al. Eosinophilic Esophagitis in children and adults: a systematic review and consensus recommendation for diagnosis and treatment. Gastroenterology. 2007;133:1342–63.CrossRefPubMedGoogle Scholar
  44. 44.
    Arora AS, Perrault J, Smyrk TC. Topical corticosteroid treatment of dysphagia due to eosinophilic esophagitis in adults. Mayo Clin Proc. 2003;63:3–12.Google Scholar
  45. 45.
    Stein MK, Collins MH, Villanuaeva JM, et al. Anti-IL-5 therapy for eosinophilic esophagitis. J Allergy Clin Immunol. 2006;118:1312–9.CrossRefPubMedGoogle Scholar
  46. 46.
    Macht M, Wimbish T, Benson AB, Burnham EL, et al. Post extubation failure is persistent and associated with poor outcomes in survivors of critical illness. Crit Care. 2011;15:R231.CrossRefPubMedCentralPubMedGoogle Scholar
  47. 47.
    Macht M, Wimbish T, Moss M. ICU-acquired swallowing disorders. Crit Care Med. 2013;41(10):2396–405.CrossRefPubMedGoogle Scholar
  48. 48.
    Rose S, Young MA, Reynolds JC. Gastrointestinal manifestations of scleroderma. Gastroenterol Clin North Am. 1998;27:563–94.CrossRefPubMedGoogle Scholar
  49. 49.
    Lapadula G, Muolo P, Semeraro F, et al. Esophageal motility disorders in rheumatic diseases: a review of 150 patients. Clin Exp Rheumatol. 1994;12:515–21.PubMedGoogle Scholar
  50. 50.
    Gareth JM, Winkleman RK, Schlegel JF, Code CF. Esophageal deterioration in scleroderma. Mayo Clin Proc. 1971;46:92–6.Google Scholar
  51. 51.
    Bassotti G, Battaglia E, Debernandi V, et al. Esophageal dysfunction in scleroderma: relationship with disease subsets. Arthritis Rheum. 1997;49:2252–9.CrossRefGoogle Scholar
  52. 52.
    Ebert EC. Esophageal disease in scleroderma. J Clin Gastroenterol. 2006;40:769–75.CrossRefPubMedGoogle Scholar
  53. 53.
    Sjogren RW. Gastrointestinal motility disorders in scleroderma. Arthritis Rheum. 1994;37:1265–82.CrossRefPubMedGoogle Scholar
  54. 54.
    Janssen M, Dijkmans BAC, Lamers CBHW. Upper gastrointestinal involvement in rheumatoid arthritis patients: intrinsic or extrinsic pathogenesis? Scand J Gastroenterol. 1990;25 Suppl 178:79–83.CrossRefGoogle Scholar
  55. 55.
    Sheehan NJ. Dysphagia and other manifestations of esophageal involvement in the musculoskeletal diseases. Rheumatology. 2008;47:746–52.CrossRefPubMedGoogle Scholar
  56. 56.
    Medrano M. Dysphagia in a patient with rheumatoid arthritis and iron deficiency anaemia. MedGenMed. 2002;4:10.PubMedGoogle Scholar
  57. 57.
    Pehlivanov N, Liu J, Mittal RK. Sustained esophageal contraction: a motor correlate of heartburn symptom. Am J Physiol Gastrointest Liver Physiol. 2001;281:G743–51.PubMedGoogle Scholar

Copyright information

© Springer India 2015

Authors and Affiliations

  1. 1.Internal Medicine and Intensive CarePD Hinduja National HospitalMahim, MumbaiIndia

Personalised recommendations